Steris PLC (N:STE)
Business Focus: Medical Equipment, Supplies & Distribution
| Sector: Healthcare | Industry: Medical Equipment, Supplies & Distribution |
| See Regulatory Filings on SEC | |
| Company Contact | |
| Address: | Block a Riverside IV 70 Sir John Rogerson's Quay DUBLIN 2 |
| Tel: | 1-440-3927245 |
| Website: | https://www.steris.com |
| IR: | See website |
| Key People | ||
| Daniel A. Carestio President, Chief Executive Officer, Director | Michael Joseph Tokich Chief Financial Officer, Senior Vice President | Mary Clare Fraser Chief Human Resource Officer, Senior Vice President |
| John Adam Zangerle Senior Vice President, General Counsel, Company Secretary | Andrew Xilas Senior Vice President, General Manager - Dental | Julia K. Madsen Senior Vice President - Life Sciences |
| Cary L. Majors Senior Vice President and President, Healthcare | Karen L. Burton Chief Accounting Officer, Vice President, Controller | Renato G. Tamaro Vice President and Corporate Treasurer |
| Business Overview |
| STERIS plc is a provider of products and services that support patient care with an emphasis on infection prevention. The Company's segments include Healthcare, Applied Sterilization Technologies, Life Sciences and Dental. The Healthcare segment is focused on sterile processing departments and procedural centers, such as operating rooms and endoscopy suites. Its Applied Sterilization Technologies (AST) segment is a third-party service provider for contract sterilization, as well as testing services needed to validate sterility services for medical device and pharmaceutical manufacturers. Its Life Sciences segment provides a comprehensive offering of products and services that support pharmaceutical manufacturing, primarily for vaccine and other biopharma customers focused on aseptic manufacturing. Its Dental segment provides a comprehensive offering for dental practitioners and dental schools, offering instruments, infection prevention consumables and instrument management systems. |
| Financial Overview |
| For the nine months ended 31 December 2023, Steris PLC revenues increased 13% to $4.02B. Net income totaled $379.6M vs. loss of $80.2M. Revenues reflect Healthcare segment increase of 18% to $2.61B, Life Sciences segment increase of 8% to $411.1M, Applied Sterilization Technologies segment increase of 4% to $703.1M, United States segment increase of 14% to $2.95B, Other locations segment increase of 9% to $1.01B. |
| Employees: | 17,000 as of Mar 31, 2023 |
| Reporting Currency: | U.S. Dollars |
| Enterprise value: | $22,957M as of Dec 31, 2023 |
| Annual revenue (TTM): | $5,407M as of Dec 31, 2023 |
| EBITDA (TTM): | $1,432M as of Dec 31, 2023 |
| Net annual income (TTM): | $566.84M as of Dec 31, 2023 |
| Free cash flow (TTM): | $398.22M as of Dec 31, 2023 |
| Net Debt Last Fiscal Year: | $3,114M as of Dec 31, 2023 |
| Shares outstanding: | 98,814,035 as of Feb 5, 2024 |
| Index Membership: | S&P 500 |
| TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization | |
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Insidertracking.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Insider information is based on filings made either on EDGAR®
or on the System for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission. Copyright © 2024 INK Research Corp. All rights reserved.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.